MoneyWorks4Me

Caplin Point Laboratories board recommends final dividend

12 Nov 2012 Evaluate

Caplin Point Laboratories has informed that the board of directors of the company at its meeting held on November 09, 2012, has recommended dividend a final dividend of Rs. 2 per share (20%) on the equity capital for the year ended June 30, 2012.

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..